Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates

Neonatal alloimmune thrombocytopenia

Massachusetts General Hospital – Healthy Naturally Cycling Women

Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women Monitoring Outcome in Neonatal Thrombocytopenia Towards Routine HPA-screening In Pregnancy to Prevent FNAIT Kinetics of Blood Platelets Transfused to Healthy Subjects Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates